Navigation Links
JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
Date:5/10/2011

se events commonly observed with SYMLIN when co-administered with insulin were mostly gastrointestinal in nature, including nausea, which was the most frequently reported adverse event. The incidence of nausea was higher at the beginning of SYMLIN treatment and decreased with time in most patients. The incidence and severity of nausea are reduced when SYMLIN is gradually increased to the recommended doses.

About JDRF

JDRF is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.

The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump - each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.

Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.5 billion to diabetes research, including $107 million last year. More than 80 percent of JDRF's expenditures directly support research and research-related education. For more information, please visit www.jdrf.org.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development, and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) inj
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Juvenile Diabetes Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference
2. Amylin Pharmaceuticals to Present at the Deutsche Bank 36th Annual Healthcare Conference
3. Amylin Pharmaceuticals Reports First Quarter Financial Results
4. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
5. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
6. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
7. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
8. Amylin Pharmaceuticals Reports 2010 Financial Results
9. Amylin Pharmaceuticals to Webcast Year-End Financial Results
10. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014   Zacks Equity Research ... Bull of the Day and Panera (Nasdaq: PNRA - Free ... Equity Research provides analysis on Amicus Therapeutics (Nasdaq: FOLD - ... and Shire (Nasdaq: SHPG - Free Report ). ... Bull of the Day : The biotech ...
(Date:8/22/2014)... , August 22, 2014 ... Hospital TVs Today Lincor announced general availability ... Engagement solution that delivers a range of education, entertainment ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , ... defining point of care patient engagement to bedside smart ...
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
Breaking Medicine Technology:Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Lincor Unveils Next Generation TV-based Patient Engagement Solution 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... Sept, 21 OmniComm Systems, Inc. (OTC ... of eClinical solutions and services announced that it will ... at the Hilton Beach Resort in Fort Lauderdale, Florida ... presentations and speakers from participating Life Science organizations. The ...
... The Pittsburgh Life Sciences Greenhouse (PLSG), the ... and business growth programs to western Pennsylvania,s life ... nationally recognized Executives-in-Residence (EIR) has launched a new ... (Ib2C(TM)). Ib2C(TM) Founder and CEO, Stephen ...
Cached Medicine Technology:OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 2OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 3Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 2Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 3Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 4
(Date:8/22/2014)... August 22, 2014 AWeber, one ... that currently helps more than 120,000 small businesses ... the attention of Shane Michaels, prompting an investigative review. ... element for any online marketing campaign, despite what some ... the marketing world,” reports Michaels. “AWeber is a great ...
(Date:8/22/2014)... MyWriters.com , an online source for ... for marketers to help them drive traffic to their ... Shane Michaels, prompting an investigative review. , “Anyone ... knows that content is king when it comes to ... even though content is extremely important, creating quality, original ...
(Date:8/22/2014)... This report studies the "Sample Preparation Market by ... Kits (Isolation, Purification), By Application (Genomics, Proteomics), by ... 2018" This market was valued at $4,254.8 million ... a CAGR of 5.9% from 2013 to 2018, ... 98 market data Tables and 23 Figures spread ...
(Date:8/22/2014)... Boston, Mass. (PRWEB) August 22, 2014 ... Chain Drug Stores (NACDS) Total Store Expo - which ... Boston Globe published a pro-pharmacy op-ed in its online ... medical care, enlist pharmacists ” is co-authored by Steven ... and Michael Malloy, PharmD, dean of the MCPHS University ...
(Date:8/22/2014)... Millennium Treatment Group has recently noticed an increase ... of drug use among teenagers. The treatment facility aims to ... work to minimize drug abuse. , America is currently seeing ... in history. According to the National Institute of Drug ... 12 or older—or 9.2 percent of the population—had used an ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... passed on a rare side effect of the smallpox vaccination he ... , The boy who is currently being treated at University of ... percent of his body. ,Eczema vaccinatum is an unusual ... receive the shot or their close contacts. , The ...
... journal Proceedings of the National Academy of Sciences. The report ... in// preventing tuberculosis, and scientists may do well to resurrect ... led by Dr. Roland Brosch of the Institut Pasteur ... vaccines used in immunization of 2 million children around ...
... the first in the state to perform a novel ... regeneration of the heart muscle after a// heart attack. ... in the country providing this new treatment modality as ... a privately funded cell-therapy company studying stem cells for ...
... gene variants in Hispanic women are linked to spontaneous preterm ... Washington University.// ,The research was presented at the ... 16. ,Preterm birth is a major cause of ... birth was suggested by racial disparity, a tendency to occur ...
... have developed a procedure that estimates the reproductive potential ... multiple births and to achieve a higher success rate ... fertilization procedures are performed each year in the United ... in IVF cycles, but only 34.3 percent resulted in ...
... part of the body, could be an indicator of common ... development of new treatment. ,Zinc had previously been ... brains of patients with Alzheimer's disease. It is also vital ... ,Zinc is particularly important for healthy skin and ...
Cached Medicine News:Health News:Toddler Infected With Rare Side Effect of Smallpox Vaccine 2Health News:TB Vaccines: Ring Out the New, Bring in the Old 2Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 2Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 3Health News:Gene Variants Linked to Preterm Birth in Hispanic Women 2
... M1 is an advanced desktop PC ... is a sophisticated 2 channel stimulation ... electrical stimulations, 2 sound stimulations and ... You can customize each stimulation independently. ...
... MagPro is the high performance magnetic stimulator for ... medical research. , ,MagPro is able to stimulate ... studies of the field/nerve interface can be done ... waveform and coil-current direction. , , , , ...
... The X-SIZER System is ... system for thrombus removal ... and saphenous vein grafts. ... steel cutter and,continuous evacuation. ...
... the perfect partner for growing your business ... scalable to meet your needs now and ... your Allura Xper FD20 system supports mixed-use ... to new technologies allows you to add ...
Medicine Products: